Scan to Download ios&Android APP

Trade Tactile Systems - TCMD CFD

10.72
0.94%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading Conditions
Long position overnight fee -0.0225%
Short position overnight fee -0.0219%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 10.62
Open* 10.39
Day's Range* 10.32 - 10.32
1-Year Change* -3.17%
Volume N/A
Average Vol. (3m) 10.519
52 wk Range N/A
Market Cap 201.522
P/E Ratio N/A
Shares Outstanding 20132100
Revenue 221.848
EPS -1.56123
Dividend (Yield %) N/A
Beta 1.54386
Next Earnings Date Nov 7, 2022

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Aug 16, 2022 10.72 0.33 3.18% 10.39 10.88 10.31
Aug 15, 2022 10.62 0.64 6.41% 9.98 10.73 9.76
Aug 12, 2022 9.97 0.16 1.63% 9.81 10.29 9.66
Aug 11, 2022 9.73 -0.03 -0.31% 9.76 10.56 9.64
Aug 10, 2022 10.26 0.77 8.11% 9.49 10.31 9.48
Aug 9, 2022 9.39 0.61 6.95% 8.78 9.53 8.78
Aug 8, 2022 9.11 0.22 2.47% 8.89 9.44 8.87
Aug 5, 2022 8.89 0.01 0.11% 8.88 9.14 8.68
Aug 4, 2022 9.01 -0.07 -0.77% 9.08 9.15 8.66
Aug 3, 2022 9.08 0.02 0.22% 9.06 9.40 8.97
Aug 2, 2022 9.11 0.92 11.23% 8.19 9.33 8.05
Aug 1, 2022 7.96 0.33 4.33% 7.63 8.06 7.35
Jul 29, 2022 7.71 -0.14 -1.78% 7.85 8.10 7.63
Jul 28, 2022 8.04 0.24 3.08% 7.80 8.20 7.78
Jul 27, 2022 8.07 0.24 3.07% 7.83 8.11 7.68
Jul 26, 2022 7.92 0.63 8.64% 7.29 7.95 7.28
Jul 25, 2022 7.62 0.61 8.70% 7.01 7.68 7.01
Jul 22, 2022 7.20 0.14 1.98% 7.06 7.61 7.04
Jul 21, 2022 7.33 -0.16 -2.14% 7.49 7.49 7.29
Jul 20, 2022 7.63 0.49 6.86% 7.14 7.92 7.14

Tactile Systems Events

Time (UTC) Country Event
Monday, November 7, 2022
21:00
  US
Q3 2022 Tactile Systems Technology Inc Earnings Release
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 84.542 109.283 143.751 189.492 187.13 208.057
Revenue 84.542 109.283 143.751 189.492 187.13 208.057
Cost of Revenue, Total 42 55.929 75.101 90.108 97.528 111.289
Gross Profit 42.542 53.354 68.65 99.384 89.602 96.768
Total Operating Expense 80.27 105.385 140.761 178.994 189.558 209.819
Selling/General/Admin. Expenses, Total 33.794 44.396 60.371 83.712 84.366 92.132
Research & Development 4.476 5.06 5.289 5.174 5.264 5.659
Operating Income 4.272 3.898 2.99 10.498 -2.428 -1.762
Other, Net 0.038 0.292 0.486 0.631 0.167 -0.531
Net Income Before Taxes 4.31 4.19 3.476 11.129 -2.261 -2.293
Net Income After Taxes 2.879 7.055 6.623 10.971 -0.62 -11.811
Net Income Before Extra. Items 2.879 7.055 6.623 10.971 -0.62 -11.811
Net Income 2.879 5.855 6.623 10.971 -0.62 -11.811
Total Adjustments to Net Income -1.247 0 0
Income Available to Common Excl. Extra. Items 1.632 7.055 6.623 10.971 -0.62 -11.811
Income Available to Common Incl. Extra. Items 1.632 5.855 6.623 10.971 -0.62 -11.811
Dilution Adjustment 0
Diluted Net Income 1.632 5.855 6.623 10.971 -0.62 -11.811
Diluted Weighted Average Shares 16.8337 18.8779 19.3476 19.6411 19.3469 19.7195
Diluted EPS Excluding Extraordinary Items 0.09695 0.37372 0.34232 0.55857 -0.03205 -0.59895
Diluted Normalized EPS 0.09695 0.37372 0.34232 0.55857 0.04859 -0.59895
Total Extraordinary Items -1.2
Unusual Expense (Income) 2.4
Depreciation / Amortization 0.739
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total revenue 42.772 51.06 52.497 61.728 47.978
Revenue 42.772 51.06 52.497 61.728 47.978
Cost of Revenue, Total 25.53 27.491 28.761 29.606 29.317
Gross Profit 17.242 23.569 23.736 32.122 18.661
Total Operating Expense 46.856 51.136 53.864 57.963 62.879
Selling/General/Admin. Expenses, Total 20.056 22.439 23.499 26.138 24.946
Research & Development 1.27 1.206 1.409 1.774 1.52
Operating Income -4.084 -0.076 -1.367 3.765 -14.901
Other, Net -0.01 -0.024 -0.12 -0.377 -0.456
Net Income Before Taxes -4.094 -0.1 -1.487 3.388 -15.357
Net Income After Taxes -2.266 1.305 -3.355 -7.495 -15.568
Net Income Before Extra. Items -2.266 1.305 -3.355 -7.495 -15.568
Net Income -2.266 1.305 -3.355 -7.495 -15.568
Income Available to Common Excl. Extra. Items -2.266 1.305 -3.355 -7.495 -15.568
Income Available to Common Incl. Extra. Items -2.266 1.305 -3.355 -7.495 -15.568
Diluted Net Income -2.266 1.305 -3.355 -7.495 -15.568
Diluted Weighted Average Shares 19.5456 20.0473 19.7908 19.8477 19.8985
Diluted EPS Excluding Extraordinary Items -0.11593 0.0651 -0.16952 -0.37763 -0.78237
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.11593 0.0651 -0.16952 -0.37763 -0.78237
Depreciation / Amortization 0.195 0.445 7.096
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 64.233 76.872 84.961 108.335 123.613 113.547
Cash and Short Term Investments 41.695 43.912 45.885 53.381 58.563 40.711
Cash & Equivalents 30.701 23.968 20.099 22.77 47.855 28.229
Short Term Investments 10.994 19.944 25.786 30.611 10.708 12.482
Total Receivables, Net 15.003 19.742 26.125 33.444 43.849 49.478
Accounts Receivable - Trade, Net 15.003 17.623 24.332 33.444 43.849 49.478
Total Inventory 6.554 11.04 11.189 19.059 18.563 19.217
Prepaid Expenses 0.981 2.178 1.762 2.451 2.638 4.141
Other Current Assets, Total 0
Total Assets 73.935 88.447 107.071 151.752 174.087 244.27
Property/Plant/Equipment, Total - Net 1.563 3.776 4.81 23.293 27.089 30.734
Property/Plant/Equipment, Total - Gross 4.362 8.123 10.45 28.604 34.465 39.777
Accumulated Depreciation, Total -2.799 -4.347 -5.64 -5.311 -7.376 -9.043
Intangibles, Net 2.394 2.218 5.339 5.312 1.68 54.081
Note Receivable - Long Term 2.823 2.718 1.884 4.184 9.433 12.847
Other Long Term Assets, Total 2.922 2.863 10.077 10.628 12.272 1.998
Total Current Liabilities 13.793 14.519 16.076 21.428 26.714 34.461
Accounts Payable 5.018 4.253 5.11 3.843 4.197 5.023
Accrued Expenses 7.885 9.304 10.201 16.05 18.017 19.907
Notes Payable/Short Term Debt 0 0 0 0 0 0
Other Current Liabilities, Total 0.89 0.962 0.765 1.535 4.5 6.571
Total Liabilities 14.296 15.66 17.801 39.157 49.337 116.043
Total Long Term Debt 0 0 0 0 0 51.79
Other Liabilities, Total 0.503 1.141 1.725 17.729 22.623 29.76
Total Equity 59.639 72.787 89.27 112.595 124.75 128.227
Redeemable Preferred Stock 0 0 0 0
Common Stock 0.017 0.018 0.019 0.019 0.019 0.02
Additional Paid-In Capital 62.406 70.224 79.554 91.874 104.675 119.962
Retained Earnings (Accumulated Deficit) -2.773 3.082 9.705 20.676 20.056 8.245
Other Equity, Total -0.011 -0.044 -0.008 0.026
Total Liabilities & Shareholders’ Equity 73.935 88.447 107.071 151.752 174.087 244.27
Total Common Shares Outstanding 16.8337 17.8464 18.6311 19.1527 19.4927 19.8778
Treasury Stock - Common -0.493 0
Goodwill, Net 31.063
Current Port. of LT Debt/Capital Leases 2.96
Long Term Debt 51.79
Deferred Income Tax 0.032
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 122.499 126.622 106.574 113.547 103.237
Cash and Short Term Investments 58.179 60.748 34.786 40.711 33.457
Cash & Equivalents 46.925 49.007 22.401 28.229 21.15
Short Term Investments 11.254 11.741 12.385 12.482 12.307
Total Receivables, Net 40.043 42.629 44.257 49.478 45.927
Accounts Receivable - Trade, Net 40.043 42.629 44.257 49.478 45.927
Total Inventory 22.042 21.153 23.83 19.217 19.479
Prepaid Expenses 2.235 2.092 3.701 4.141 4.374
Total Assets 175.276 181.632 249.395 244.27 233.012
Property/Plant/Equipment, Total - Net 26.311 25.537 30.377 30.734 29.645
Intangibles, Net 1.683 1.702 54.97 54.081 53.169
Note Receivable - Long Term 10.727 11.874 12.422 12.847 13.577
Other Long Term Assets, Total 14.056 15.897 13.989 1.998 2.321
Total Current Liabilities 27.985 26.643 31.309 34.461 40.273
Accounts Payable 9.352 5.06 6.192 5.023 6.2
Accrued Expenses 13.74 16.337 18.084 19.907 17.658
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 4.893 5.246 4.823 6.571 13.451
Total Liabilities 50.154 48.916 117.289 116.043 118.034
Total Long Term Debt 0 0 52.517 51.79 48.077
Other Liabilities, Total 22.169 22.273 33.463 29.76 29.537
Total Equity 125.122 132.716 132.106 128.227 114.978
Common Stock 0.02 0.02 0.02 0.02 0.02
Additional Paid-In Capital 107.312 113.601 116.346 119.962 122.281
Retained Earnings (Accumulated Deficit) 17.79 19.095 15.74 8.245 -7.323
Total Liabilities & Shareholders’ Equity 175.276 181.632 249.395 244.27 233.012
Total Common Shares Outstanding 19.6391 19.7823 19.7977 19.8778 19.9398
Redeemable Preferred Stock 0 0 0
Goodwill, Net 31.063 31.063 31.063
Current Port. of LT Debt/Capital Leases 2.21 2.96 2.964
Long Term Debt 52.517 51.79 48.077
Deferred Income Tax 0.032 0.147
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line 2.879 5.855 6.623 10.971 -0.62 -11.811
Cash From Operating Activities 7.033 4.192 9.007 2.51 2.794 2.631
Cash From Operating Activities 0.799 1.849 3.635 3.538 2.794 3.681
Deferred Taxes -0.611 0.143 -6.182 -0.146 -1.233 10.23
Non-Cash Items 2.457 4.536 10.512 10.672 14.612 9.993
Cash Taxes Paid 2.158 0.923 2.883 0.344 0.543 1.593
Cash Interest Paid 0 0 0.009 0 0 0.13
Changes in Working Capital 1.509 -8.191 -5.581 -22.525 -12.759 -9.462
Cash From Investing Activities -11.844 -14.016 -14.726 -2.335 20.179 -82.184
Capital Expenditures -0.833 -3.82 -9.546 -5.988 -2.291 -2.355
Other Investing Cash Flow Items, Total -11.011 -10.196 -5.18 3.653 22.47 -79.829
Cash From Financing Activities 28.452 3.091 1.85 2.496 2.112 59.927
Financing Cash Flow Items -4.777 -0.387 -2.379 -3.391 -1.854 -1.361
Total Cash Dividends Paid -8.207
Issuance (Retirement) of Stock, Net 41.436 3.478 4.229 5.887 3.966 6.288
Issuance (Retirement) of Debt, Net 0 55
Net Change in Cash 23.641 -6.733 -3.869 2.671 25.085 -19.626
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line -2.266 -0.961 -4.316 -11.811 -15.568
Cash From Operating Activities -0.8 -1.917 -2.975 2.631 -3.206
Cash From Operating Activities 0.652 1.287 2.15 3.681 1.507
Deferred Taxes -1.828 -3.581 -1.709 10.23 0.115
Non-Cash Items 2.457 5.115 7.71 9.993 8.678
Cash Taxes Paid 0.013 1.141 1.541 1.593 0.012
Changes in Working Capital 0.185 -3.777 -6.81 -9.462 2.062
Cash From Investing Activities -0.311 -0.743 -81.237 -82.184 -0.175
Capital Expenditures -0.311 -0.743 -1.408 -2.355 -0.175
Other Investing Cash Flow Items, Total 0 0 -79.829 -79.829
Cash From Financing Activities 0.181 3.812 58.758 59.927 -3.698
Financing Cash Flow Items -1.115 -1.115 -1.368 -1.361 -0.039
Issuance (Retirement) of Stock, Net 1.296 4.927 5.126 6.288 0.091
Net Change in Cash -0.93 1.152 -25.454 -19.626 -7.079
Issuance (Retirement) of Debt, Net 55 55 -3.75
Cash Interest Paid 0.13 0.413

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group
427000+

Traders

71000+

Active clients monthly

$46000000+

Monthly investing volume

$17000000+

Withdrawn each month

Tactile Systems Company profile

About Tactile Systems Technology Inc

Tactile Systems Technology, Inc. is a medical technology company focused on developing medical devices for the treatment of chronic diseases. Its therapeutic focus is vascular disease, for treating lymphedema and chronic venous insufficiency. It is a manufacturer and distributor of the Flexitouch and Entre systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition. Its at-home Flexitouch system provides automated, at-home lymphatic drainage therapy. Its Flexitouch Plus system is an automated, programmable, pneumatic compression device (APCD), designed for the treatment of lymphedema in the home setting. Its Entre system is a pneumatic compression device used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. It possesses a platform to deliver at-home healthcare solutions directly to patients throughout the United States.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Tactile Systems Technology Inc revenues increased 11% to $208.1M. Net loss increased from $620K to $11.8M. Revenues reflect Flexitouch system segment increase of 8% to $176.2M, Entre/Actitouch systems segment increase of 15% to $26.7M. Higher net loss reflects Sales and marketing - Balancing value increase of 11% to $82.7M (expense), Stock-based Compensation in SGA increase of 13% to $5.4M (expense).

Industry: Medical Equipment

1331 Tyler St NE Ste 200
MINNEAPOLIS
MINNESOTA 55413-1638
US

Income statement

People Also Watch

US Crude Oil Spot

86.69 Price
-0.680% 1D Chg, %
Long position overnight fee 0.0115%
Short position overnight fee -0.0286%
Overnight fee time 21:00 (UTC)
Spread 0.03

Still looking for a broker you can trust?

Join the 427.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading